Cargando…
Role of Mitochondria in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) affects about 30% of the general population in the United States and includes a spectrum of disease that includes simple steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. Significant insight has been gained into our understanding of the...
Autores principales: | Nassir, Fatiha, Ibdah, Jamal A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057755/ https://www.ncbi.nlm.nih.gov/pubmed/24837835 http://dx.doi.org/10.3390/ijms15058713 |
Ejemplares similares
-
Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016) -
Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice
por: Nassir, Fatiha, et al.
Publicado: (2018) -
Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
por: Ramanathan, Raghu, et al.
Publicado: (2022) -
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
por: Di Ciaula, Agostino, et al.
Publicado: (2021) -
Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy
por: Natarajan, Sathish Kumar, et al.
Publicado: (2018)